Dual effect of DMPP on the resting release of noradrenaline from rat hippocampal slices

Brain Research Bulletin

Volumn 43, Issue 3, 1997, Pages 257-262

  Kiss, Janos P ^a   Windisch, Katalin ^a   Balla, Andrea ^a   Sershen, Henry ^b   Lajtha, Abel ^b  

^a INSTITUTE OF EXPERIMENTAL MEDICINE   (Hungary)

^b NATHAN S KLINE INSTITUTE FOR PSYCHIATRIC RESEARCH   (United States)

Author keywords

Carrier mediated release; DMPP; Exocytosis; Hippocampus; Nicotinic receptors; Noradrenaline release

Indexed keywords

1,1 DIMETHYL 4 PHENYLPIPERAZINIUM; 14ALPHA HYDROXY 7,8 METHYLENEDIOXYALLOBERBANE; ALPHA 2 ADRENERGIC RECEPTOR BLOCKING AGENT; CADMIUM; DESIPRAMINE; MECAMYLAMINE; NICOTINIC AGENT; NICOTINIC RECEPTOR BLOCKING AGENT; NISOXETINE; NOMIFENSINE; NORADRENALIN; PANCURONIUM; PIPECURONIUM; TETRODOTOXIN;

ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; FEEDBACK SYSTEM; HIPPOCAMPUS; HORMONAL REGULATION; HORMONE ACTION; MALE; NONHUMAN; NORADRENALIN RELEASE; PRESYNAPTIC INHIBITION; PRIORITY JOURNAL; RAT;

ANIMALS; DIMETHYLPHENYLPIPERAZINIUM IODIDE; DOSE-RESPONSE RELATIONSHIP, DRUG; HIPPOCAMPUS; MALE; NOREPINEPHRINE; RATS; RATS, WISTAR;

EID: 0030981651     PISSN: 03619230     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0361-9230(96)00339-5     Document Type: Article

References (27)

1. Arqueros L., Naquira D., Zunino E. Nicotine-induced release of catecholamines from rat hippocampus and striatum. Biochem. Pharmacol. 27:1978;2667-2674.
2. 3H]-dopamine release. Br. J. Pharmacol. 117:1996;595-606.
3. Fielding S., Szewczak M. R. Pharmacology of nomifensine: A review of animal studies. J. Clin. Psychiatry. 45:1984;12-20.
4. Holbach H. J., Lindmar R., Loffelholz K. DMPP and the adrenergic nerve terminal: Mechanisms of noradrenaline release from vesicular and extravesicular compartments. Naunyn Schmiedebergs Arch. Pharmacol. 300:1977;131-138.
5. Kirpekar S. M., Garcia A. G., Prat J. C. Action of nicotine on sympathetic nerve terminals. J. Pharmacol. Exp. Ther. 213:1980;133-138.
6. Kiss J. P., Zsilla G., Mike A., Zelles T., Toth E., Lajtha A., Vizi E. S. Subtype-specificity of the presynaptic alpha 2-adrenoceptors modulating hippocampal norepinephrine release in rat. Brain Res. 674:1995;238-244.
7. 3H-noradrenaline. Naunyn Schmiedebergs Arch. Pharmacol. 336:1987;611-620.
8. Lee E. H., Ma Y. L. Amphetamine enhances memory retention and facilitates norepinephrine release from the hippocampus in rats. Brain Res. Bull. 37:1995;411-416.
9. Levi G., Raiteri M. Carrier-mediated release of neurotransmitters. Trends. Neurosci. 16:1993;415-419.
10. Matta S. G., McCoy J. G., Foster C. A., Sharp B. M. Nicotinic agonists administered into the fourth ventricle stimulate norepinephrine secretion in the hypothalamic paraventricular nucleus: An in vivo microdialysis study. Neuroendocrinology. 61:1995;383-392.
11. Mitchell S. N. Role of the locus coeruleus in the noradrenergic response to a systemic administration of nicotine. Neuropharmacology. 32:1993;937-949.
12. Mulle C., Choquet D., Korn H., Changeux J. P. Calcium influx through nicotinic receptor in rat central neurons: Its relevance to cellular regulation. Neuron. 8:1992;135-143.
13. Muscholl E. Cholinomimetic drugs and release of adrenergic transmitter. Schümann H. J., Kroneberg G. New aspects of storage and release mechanisms of catecholamines. 1970;168-186 Springer, Berlin.
14. 3H-noradrenaline by dimethylphenylpiperazinium (DMPP) in the rat vas deferens. Naunyn Schmiedebergs Arch. Pharmacol. 341:1990;43-49.
15. Rana B., McMorn S. O., Reeve H. L., Wyatt C. N., Vaughan P. F., Peers C. Inhibition of neuronal nicotinic acetylcholine receptors by imipramine and desipramine. Eur. J. Pharmacol. 250:1993;247-251.
16. Richardt G., Haass M., Neeb S., Hock M., Lang R. E., Schomig A. Nicotine-induced release of noradrenaline and neuropeptide Y in guinea pig heart. Klin. Wochenschr. 66:((Suppl 11)):1988;21-27.
17. Ridley R. M., Baker H. F., Harder J. A., Pearson C. Effects of lesions of different parts of the septo-hippocampal system in primates on learning and retention of information acquired before or after surgery. Brain Res. Bull. 40:1996;21-32.
18. Sacaan A. I., Dunlop J. L., Lloyd G. K. Pharmacological characterization of neuronal acetylcholine gated ion channel receptor-mediated hippocampal norepinephrine and striatal dopamine release from rat brain slices. J. Pharmacol Exp. Ther. 274:1995;224-230.
19. 2 -adrenoceptors and protein kinase C on nicotine-induced facilitation of noradrenaline release in bovine cerebral arteries. Gen. Pharmacol. 26:1995;827-833.
20. Sershen H., Toth E., Lajtha A., Vizi E. S. Nicotine effects on presynaptic receptor interactions. Ann. NY Acad. Sci. 757:1995;238-244.
21. Thorne B., Potter P. E. Lesion with the neurotoxin AF64A alters hippocampal cholinergic receptor function. Brain Res. Bull. 38:1995;121-127.
22. Todorov L., Windisch K., Shersen H., Lajtha A., Papasova M., Vizi E. S. Prejunctional nicotinic receptors involved in facilitation of stimulation-evoked noradrenaline release from the vas deferens of the guinea pig. Br. J. Pharmacol. 102:1991;186-190.
23. Vaughan P. F., Kaye D. F., Reeve H. L., Ball S. G., Peers C. Nicotinic receptor-mediated release of noradrenaline in the human neuroblastoma SH-SY5Y. J. Neurochem. 60:1993;2159-2166.
24. Vizi E. S., Harsing L. G. Jr., Zimanvi I., Gaal G. Release and turnover of noradrenaline in isolated median eminence: lack of negative feedback modulation. Neuroscience. 16:1985;907-916.
25. Vizi E. S., Kiss J., Elenkov I. J. Presynaptic modulation of cholinergic and noradrenergic neurotransmission: Interaction netween them. News Physiol. Sci. 6:1991;119-123.
26. Vizi E. S., Sershen H., Balla A., Mike A., Windisch K., Juranyi Z., Lajtha A. Neurochemical evidence of heterogeneity of presynaptic and somatodendritic nicotinic acetylcholine receptors. Ann. NY Acad. Sci. 757:1995;84-99.
27. 2 -adrenoceptor antagonists. J. Med. Chem. 30:1987;1355-1359.